Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): Consensus statements and report from an expert workshop
Several new treatments for
IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
Several new treatments for
We have utilized the computerized data of a nationwide health plan to elucidate several epidemiologic aspects and risk factor of
No abstract available.
Histone methylation is a type of epigenetic modification that is critical for the regulation of gene expression. Numerous studies have demonstrated that abnormalities of this newly characterized epigenetic modification are involved in the development of multiple diseases, including cancer. There is also emerging evidence for a link between histone methylation and the pathogenesis of myeloid neoplasms, including
Background. There are limited reports of thrombosis among myelodysplastic syndrome patients exposed to erythropoiesis stimulating agents.
Allogeneic hematopoietic stem cell transplantation is still the only potentially curative treatment for patients with
Sustained clinical cytopenia is a frequent laboratory finding in ambulatory and hospitalized patients. For pathologists and hematopathologists who examine the
Allogeneic stem cell transplantation (SCT) is the treatment of choice for young patients (age ≤ 55 years) with
Introduction:
No abstract available